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Cloning, Expression, and Sequence Analysis of Camelysin, a Zinc
Metalloprotease from Bacillus anthracis and B. cereus
Andrew Ross Myers
ABSTRACT
Bacillus anthracis and B. cereus are well known etiological agents, which
cause disease in healthy and immunocompromised individuals. Considering the
abundance and lethality of these organisms it is imperative that research is
performed to identify and analyze new factors that may contribute to their
pathogenicity. Camelysin is a membrane bound, zinc metalloprotease isolated
from B. cereus. Assays performed on purified camelysin demonstrate that the
protease exhibits fibrinolytic, collagenolytic, and actin degradation activity, any of
which can contribute to the organism’s ability to invade host tissues and cause
damage. Considering the putative role of camelysin in pathogenicity, it would be
beneficial to study the effects of camelysin in tissue cultures or animal models.
The goal of this study focused on the cloning and expression of camelysin from
B. cereus and its homolog in B. anthracis. Expression of a fusion tagged protein
may assist in the purification of camelysin as well as overcoming the native
protein’s extreme insolubility. Primers were designed to amplify the camelysin
gene from B. cereus for cloning into the prokaryotic pBAD TOPO® TA,
pET100/D-TOPO®, and the eukaryotic pcDNA3.1/V5-His© TOPO® TA expression
vii

vectors. Primers were also designed to amplify the gene from B. anthracis for
cloning into the pBAD TOPO® TA vector. The recombinant clones were induced
and successful expression of the protein was confirmed by performing SDSPAGE, Western blotting, and an azocasein protease assay. The recombinant
proteins exhibited casein degradation activity which is observed with purified
camelysin from B. cereus. This study successfully demonstrated the presence of
the camelysin protein in B. anthracis. Furthermore, the recombinant clones
obtained will be useful for purification and analysis of camelysin and delineation
of its role in the pathogenicity of B. cereus and B. anthracis.

viii

INTRODUCTION
Bacillus anthracis and Bacillus cereus are known pathogens, which have
various effects on the human body. Both healthy and immunocompromised
individuals can become infected with these organisms and both B. anthracis and
B. cereus contain many similar virulence factors (20). There have been
numerous studies performed which have identified the main factors of
pathogenicity in these organisms, and most have resulted in therapeutic
treatments against these commonly known factors. Most of these treatments
however are ineffective by the time physicians identify the presence of these
pathogens, due to the fact that some are often considered clinical laboratory
contaminants (10, 31). However, to this date there have been no recent studies
aimed at identifying any new pathogenicity factors in these organisms that could
be of therapeutic value. This study focused on the identification and expression
of a zinc metalloprotease, camelysin, in B. cereus ATCC 14579 and B. anthracis,
which share many common factors of pathogenicity (15).
B. anthracis, B. cereus, and B. thuringiensis are all Gram positive, rod
shaped, spore forming, facultative aerobes, and most have plasmids that encode
toxins. They are commonly found in the soil, and all are classified as group I
bacilli, which contains most of the bacilli that cause infection, and all three
organisms are indistinguishable from each other based on 16srRNA analysis (10,
1

20, 31, 36, 38). All three have plasmids, some encoding toxins like the pXO1
found in B. anthracis, and pBc10987 of B. cereus which is homologous to the
pXO1 plasmid, but lacks the genes producing the lethal and edema toxins (38).
The spore forms of these organisms are resistant to heat, gamma radiation, and
even hospital based antimicrobial handwashes and disinfectants (22, 10). B.
anthracis and B. cereus mainly affect humans, while B. thuringiensis affects
insects. Due to this fact, our study concentrated on the screening and
identification of the camelysin gene from B. anthracis and B. cereus ATCC
14579.
The ten main infections resulting from B. cereus include local infections of
burns or trauma, septicemia and bacteremia, meningitis, respiratory infections,
endocarditis, urinary tract infections, skin infection, eye infections, osteomyelitis,
and food poisoning (10, 22, 23). B. cereus mainly causes gastrointestinal
distress resulting from contaminated food, but is also know to cause nongastrointestinal disease in immunocompromised people such as individuals with
AIDS, newborns, people recovering from surgery, and IV drug users (10, 22).
The main drug users affected by B. cereus infections are those who are heroin
addicts, not just because the needles may become contaminated with
pathogens, but due to the fact that B. cereus often is found as a contaminate of
heroin (22).
The most prevalent infection associated with B. cereus is a result of
ingestion of contaminated foods such as rice, pasta, and dairy products (22).
There are two types of food poisoning that affect humans: the emetic food
2

poisoning, and the diarrheal food poisoning. The diarrheal food poisoning is
caused by the HBL and NHE enterotoxin complexes, which induce the following
symptoms: abdominal pain, cramps, rarely a fever, occasional vomiting, and
diarrhea which last for 1 to 2 days (10, 22). Vomiting usually starts 10 hours after
ingestion since the toxin can be preformed (10). This type of food poisoning is
similar to that of Clostridium perfringens, which may lead to misdiagnosis of B.
cereus infections.
The emetic food poisoning is caused by the heat resistant toxin, cereulide,
which is a type of hemolysin (22). Symptoms of the emetic food poisoning
appear similar to the food poisoning of Staphylococcus aureus and include
nausea, vomiting, and occasional diarrhea (10, 22). Since the toxin is always
preformed it can cause symptoms in as little as 15 minutes.
Since the gastrointestinal infections are the most common result of a B.
cereus infection, physicians tend to overlook cases in which B. cereus is the
source of the infection. This stems from the fact that B. cereus infections are not
routinely screened for in some countries because they are not listed as
reportable illnesses (22). This is a strange fact, especially since B. cereus is
commonly found in the hospital environment, sometimes causing nosocomial
infections (2, 5, 19, 27). One patient undergoing neurosurgery developed
meningitis due to linens contaminated with B. cereus (22). Another example
included the misdiagnosis of B. cereus infections in two people in Louisiana (31).
The first patient exhibited symptoms of pneumonia 5 days before admission into
the hospital, where he was diagnosed with a lung tumor and died that same day.
3

The second patient was admitted to the hospital after 3 days of symptoms, was
diagnosed with tuberculosis and died 3 days later. Both were given antibiotics
that should have treated the infection, however they received them too late,
sepsis overtook their bodies and was later determined to be the cause of death in
both individuals (31). This is why it is important that studies be continued on B.
cereus that focus on identification of new virulence factors and faster methods to
detect the pathogen.
B. anthracis mainly infects the respiratory tract of individuals although rare
cases of gastrointestinal infections have been reported. The main factors
contributing to the virulence of B. anthracis include a toxin complex, the ability of
the organism to form spores that are easily aerosolized, as well as a capsule that
is present in its virulent form which may help the organism evade the immune
system (29, 34, 38). B. anthracis has two large plasmids (pXO1 and pXO2) that
encodes for proteins that must be present for the organism to be fully virulent (1).
pXO1 is the plasmid that contains the genes for the toxin complex. The toxin
complex is made up of the edema factor, lethal factor, and protective antigen
encoded by cya, lef, and pagA respectively (38). The protective antigen is a
major component of the cell free vaccines on the market that are for human use
(1). pXO1 is 182 kb and the pathogenicity island which contains cya, lef, and
pagA, is only 44.8 kb in size, the island is surrounded by two IS1627 elements
thus suggesting that it may be mobile (38). Plasmid pXO2 contains the gene that
encodes for the Poly-d-glutamic acid capsule that aids in antiphagocytic activity
(34). Although treatments and a vaccine are available for this organism, they are
4

not as effective as treatments for simple infections such as gastroenteritis. More
work needs to be done to identify new virulence factors, and this study will
encompass the use of B. anthracis, since sequence information has identified a
putative camelysin gene in its genome.
Camelysin is a membrane bound neutral zinc metalloprotease with a
molecular mass of approximately 19 kDa and is found in an uncharacterized
strain of B. cereus while in the logarithmic phase of growth (15, 16, 24). The
camelysin protein also known as casein cleaving metalloprotease, has been
studied and characterized within the last ten years. Recent studies have outlined
camelysin as a possible pathogenicity factor as it has fibrinolytic, collagenolytic,
and actin degradation activity (15). These activities may contribute to the ability
of B. cereus or any other organisms that contain the camelysin protein to invade
host tissues and cause damage.
Proteases are divided into two major groups; those that cleave peptide
chains at the ends, and those that cleave the peptide chains towards the middle,
these are exopeptidases and endopeptidases respectively (37). Next the
proteases are further classified by the residues that are at their active site into
serine, aspartic, cysteine, and metallo-proteases. Metalloproteases usually
require divalent metal ions for activity (37). Zinc peptidases consist of 30 families
and are divided into 5 major clans (25, 37). The HEXXH motif is typically found
in zinc metalloproteases at the zinc-binding region and is usually contained in an
alpha helical region of the protein (26).

5

The first studies on camelysin were focused on establishing a number of
general characteristics. The molecular weight was determined first by SDSPAGE and then by mass spectrometry. SDS-PAGE performed (under reducing
conditions, beta-mercaptoethanol) showed two bands, one at 58 kDa and the
other at 64 kDa (13). Under non-reducing conditions the protease exhibits selfaggregation on the top part of the gel (13, 15). Even after boiling for several
minutes with SDS, the protease was able to form aggregates. This selfaggregation is possibly caused by the oligomerization of the protease, which may
explain the different molecular mass obtained by mass spectrometry (indicated
MW= 19 kDa) as compared to SDS-PAGE.
Purified camelysin is shown to have the characteristics of an
endopeptidase, which is a protease that cleaves towards the middle of the
proteins, and may be involved in several pathogenicity pathways (37).
Camelysin is able to cleave collagen type I, the most abundant collagen type that
is found in skin, bones, and tendons (15). The protease cleaved the heterotrimer
(collagen) in a similar manner to other bacterial collagenases (15). Other studies
have found unidentified collagenases present during the log phase of growth on
the outer membrane of B. cereus that may be responsible for binding to host
cells. There is another hypothetical collagenase that may play a role in the
degradation of collagen, which protects the lens capsule of the eye (2). B.
cereus is known to cause ocular infections (endophthalmitis) by interacting with
other pathogenicity factors which may play a role in these infections (15).
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Camelysin has also been shown to activate plasminogen to plasmin and
also destroys 2-antiplasmin. 2-antiplasmin keeps plasmin from degrading fibrin
clots by forming a complex with it, and inactivating it (15). Cleavage of actin is
also catalyzed by camelysin, and this could be a possible mechanism associated
with the diarrheal effects of the organism (15).
Other zinc metalloproteases of different organisms have been shown to
cause damage to cellular structures (7). One example is from Vibrio vulnificus,
which has a protease that destroys collagen type IV, which results in the
breakdown and collapse of capillary vessels (32). The destruction is due to the
fact that the basal membranes surrounding the capillaries are made of collagen
and laminin and once these are digested the capillaries have no structure holding
them together, resulting in collapse and hemorrhaging. Venom from certain
snakes may also contain zinc metalloproteases that act in the same fashion. In
multiple sclerosis patients, zinc dependant matrix metalloproteases cause the
breakdown of connective tissue; under normal circumstances the collagen is
resistant to proteases because of its supercoiled triple helices and this is not the
case in MS patients (4). In some people with cancer, the concentration of matrix
metalloproteases is higher in patients who are sick as compared to those who
are healthy. In certain cancers the concentration of matrix metalloproteases is
increased during the beginning stages of metastasis and matrix metalloprotease
inhibitors are used to prevent metastasis from occurring (11, 40). Zinc
metalloproteases do not always cause damage: some actually are involved in the
formation of bone tissue and a variety of other useful biological materials (18).
7

When it came to the purification of camelysin, solubilization of the active
protein was difficult. Several non-ionic detergents were experimented with
(Triton X-100, Brij 35, and Octylthioglucoside) and none were able to solubilize
the protein in its active form (13). Later, Fricke et al. (13, 15) experimented with
Sulfobetain SB-12 and it successfully solubilized the protein in its active form.
This detergent was used to form a stable complex with the protein so it remained
stable outside of the cell membrane and it also protected the hydrophobic ends
from hydrophilic environments. Protease activity remained for several days
without the addition of phospholipids when stored at 4° C. The mechanism of the
protein removal involved the detergent replacing the phospholipids molecules in
the cell membrane when the detergent was in high concentration. Decreasing
the detergent concentration resulted in increased activity of the protease, which
shows that the absence of the phospholipids did not have an inactivating effect.
Due to the high hydrophobicity of the protein, purification of the
solubilizate is difficult. Mixed micelles form during purification between
phospholipids and different membrane proteins as well as between different
membrane proteins and the detergent (15). The detergent is also known to
cause problems column matrix, thus it must be removed or diluted before
addition to the columns (13). Conventional techniques for purification such as
hydrophobic interaction chromatography (Butyl sepharose and Phenyl
sepharose), chromatofocusing (PBE 94), and most forms of ion exchange
chromatography cannot be used due to the hydrophobicity of the aggregated
protease (15). However, in one study, ion exchange chromatography using EMD
8

TMAE Fractogel resulted in the partial purification of the protein (13). The only
way to elute the protein from the column matrix involved the use of high
concentrations of isopropanol. Subsequent studies showed that the polar
solvents caused denaturation and inactivation of camelysin. In the latest study
the purified protein was obtained using a Butyl Toyopearl column without any
major loss in enzyme activity, and the usage of polar solvents was omitted (15).
In Grass et al., 2004, the molecular characteristics of the camelysin gene
and protein were studied. Inverse PCR allowed the cloning of the gene and a
gene knockout demonstrated that it was indeed camelysin that caused the
protease activity in B. cereus (16). The studies also revealed that camelysin
lacked the HEXXH motif commonly found in zinc metalloproteases and it had no
conserved domains like most proteins, thus making it very unique. Our study will
focus on the identification of the secondary structure of camelysin using the
sequence information obtained from Dr. Grass and will be used to clone the gene
into various expression vectors. Once a suitable vector system is identified, Dr.
Grass will perform mutational studies to identify this rare zinc binding motif. This
study will also identify whether or not the camelysin gene is present in B.
anthracis and if so, further experiments will allow us to look at its possible role in
the pathogenicity of these organisms.

9

MATERIALS AND METHODS

Chemicals and Reagents
The Wizard® Genomic DNA Purification Kit, restriction enzymes, and the
PCR reagents were purchased from Promega Inc. (Madison, WI) and were used
according to the manufacturer’s protocols. PCR primers were synthesized by
Operon Biotechnologies (Huntsville, AL). PfuTurbo® DNA polymerase was
purchased from Stratagene Inc. (La Jolla, CA). The expression vectors pBAD
TOPO® TA, pcDNA3.1/V5-His© TOPO® TA, and pET100/D-TOPO® were obtained
from Invitrogen Life Technologies (Carlsbad, CA). All other chemicals and
reagents were purchased from Fisher Scientific (Pittsburg, PA), Sigma-Aldrich
Co. (St. Louis, MO), or Bio-Rad Laboratories (Hercules, CA) unless otherwise
noted.

Bioinformatics Analysis
The DNA sequence for the camelysin gene in B. anthracis Ames Strain
and B. cereus ATCC 14579 were obtained from the National Center for
Biotechnology Information (NCBI) Entrez server. Multiple sequence analysis was
performed using the GAP alignment tool from the GCG Wisconsin Package®
software (Accelrys Inc., San Diego, CA) using nucleotide, amino acid, and
10

secondary structure sequences. Predictions of the signal peptides were obtained
from the SignalP 3.0 server (3). Secondary structure predictions were obtained
using PSIPRED Protein Structure Prediction Server (21, 28).

Bacterial Strains, Eukaryotic Cells, and Growth Conditions
B. cereus ATCC 14579 was obtained from Dr. Daniel Lim (University of
South Florida Biology Department, Tampa, FL) and cultured at 37ºC in brain
heart infusion broth (Difco, Detroit, MI). HeLa cells (CCL-2) were obtained from
ATCC (Manassas, VA) for eukaryotic expression and were cultured in EMEM
supplemented with 10% FBS at 37ºC in 5% CO2. Chemically competent
Escherichia coli TOP10 cells were purchased from Invitrogen and used for the
cloning of all constructs, and the expression of BAcalY-pBAD and BCcalY-pBAD.
E. coli BL21 Star™ (DE3)pLysS cells were purchased and used for the cloning
and expression of BCcalY-pET100D. Luria-Bertani (LB) broth (Difco, Detroit, MI)
supplemented with 100g/mL ampicillin (LB-AMP) was used for culturing and
expression of camelysin in the TOP10 and BL21 transformants. Conditions for
expressing the pBAD and pET constructs included growth in LB-AMP broth at
30ºC, while conditions for mammalian cells remained the same except for the
absence of 10% FBS for four and a half hours during the transfection.
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Genomic DNA Isolation
Genomic DNA was isolated using the Promega Wizard® genomic DNA
purification kit. A 10mL overnight culture was grown in LB broth in a shaking
incubator at 37ºC. 1mL of the culture was removed and centrifuged at 16,000 X
g for 2 minutes. The cell pellet was resuspended in 480L of 50mM EDTA and
60L of a 10mg/mL solution of lysozyme, which was incubated at 37ºC for 45
minutes. The sample was centrifuged at 16,000 X g for 2 minutes and 600L of
Nuclei Lysis Solution was added to resuspend the cells. To continue the cell
lysis, the sample was incubated at 80ºC for 5 minutes. The samples were then
incubated at 37ºC for 45 minutes with 3L of RNase Solution to remove any RNA
present in the samples. After cooling to room temperature, 200L of Protein
Precipitation Solution was added to the sample, which was then placed on ice for
5 minutes to aid in the precipitation. The sample was then centrifuged at 16,000
X g for 3 minutes and the supernatant containing the DNA was transferred to a
fresh tube that contained 600L of isopropanol to precipitate the DNA. The DNA
was pelleted by centrifugation at 16,000 X g for 2 minutes. Next, the supernatant
was removed and 600L of 70% ethanol was added to rinse the pellet. The
sample containing the purified DNA was then centrifuged for another 2 minutes
at 16,000 x g. The supernatant was removed and the pellet was allowed to air
dry, after which 100L DNA Rehydration Solution was added. The resulting DNA
12

was analyzed on a 1% agarose gel for quality control, and the concentration and
purity of the DNA was determined using the SmartSpec Plus Spectrophotometer
(Bio-Rad).

PCR Amplification
PCR was performed on the genomic DNA for identification and cloning of
the camelysin gene. The PCR products for the pBAD TOPO® TA vector were
amplified using the Expand Long Template PCR System (Roche Applied
Science, Indianapolis, IN), in which each reaction contained 3 units of Taq and
Tgo polymerases, 200M of dNTP’s, 250ng of genomic DNA, 50L of Buffer 3,
and 0.4M of each primer were used (Table 2). PCR products for the pcDNA3.1
TOPO® TA vector were amplified using the PCR Mastermix (Promega) which
contains a Taq polymerase with terminal transferase activity that adds adenosine
residues onto the amplification product. For this amplification 0.625 units of Taq
polymerase, 200M of dNTP’s, 137ng of genomic DNA, and 0.4M of each
primer were used. The PCR products for the pET100/D-TOPO® were amplified
using the PfuTurbo® DNA polymerase (Stratagene), which resulted in blunt
ended PCR products. For this amplification, 2.5 units of PfuTurbo® DNA
polymerase, 200M of dNTP’s, 100ng of genomic DNA, 0.4M of each primer
(Table 2), and 1x PCR reaction buffer (Stratagene) were used. The conditions of
each PCR reaction are described in Table 1.
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Table 1. Conditions used for PCR Amplification of camelysin from B. anthracis
and B. cereus
Primer Pair
B. anthracis DNA: pBAD calY forward,
pBAD calY reverse

PCR Conditions
95ºC for 2 minutes (Initial Denaturation)
95ºC for 30 seconds (Denaturation)
55ºC for 30 seconds (Annealing)
68ºC for 1 minute (Extension)
Repeated 25 times

B. cereus DNA: pBAD calY forward,
pBAD calY reverse

68ºC for 7 minutes (Final Extension)
95ºC for 2 minutes (Initial Denaturation)
95ºC for 30 seconds (Denaturation)
55ºC for 30 seconds (Annealing)
68ºC for 1 minute (Extension)
Repeated 25 times

B. cereus DNA: pcDNA calY forward,
pcDNA calY reverse

68ºC for 7 minutes (Final Extension)
96ºC for 2 minutes (Initial Denaturation)
96ºC for 30 seconds (Denaturation)
56ºC for 30 seconds (Annealing)
72ºC for 1 minute (Extension)
Repeated 26 times

B. cereus DNA: pET calY forward, pET
calY reverse

72ºC for 15 minutes (Final Extension)
95ºC for 2 minutes (Initial Denaturation)
95ºC for 30 seconds (Denaturation)
53ºC for 30 seconds (Annealing)
72ºC for 1 minute (Extension)
Repeated 26 times
72ºC for 10 minutes (Final Extension)

Ligation into Expression Vectors and Cloning
The PCR products amplified using the Promega Taq polymerase, and the
Roche Tgo and Taq polymerases were ligated into the pcDNA3.1 TOPO® TA and
pBAD TOPO® TA vectors respectively. Briefly, 2L of the PCR products were
added to 2L of water, and 1L of the appropriate linearized vector. The ligation
reaction was incubated at room temperature for 5 minutes and placed on ice.
Transformation was completed by taking 2L of the ligation products and adding
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them to E. coli TOP10 cells, which were incubated on ice for 15 minutes. Next,
the cells were heat shocked for 30 seconds in a 42ºC water bath and 250L of
S.O.C. medium (Invitrogen) was added, followed by incubation at 37ºC for one
hour in a shaking incubator. LB-AMP plates were inoculated with 20L and 40L
volumes of each transformation reaction and incubated overnight at 37ºC.
Individual colonies were removed and screened for BAcalY-pBAD, BCcalYpBAD, or BCcalY-pcDNA using PCR amplification with primers (Table 2) specific
for either the native plasmid or the inserted camelysin gene. Restriction enzyme
digestion of BCcalY-pcDNA was also carried out using 25 units of BstX I per 1g
of plasmid DNA and results were observed on an agarose gel.
The PCR products amplified using the PfuTurbo® polymerase were ligated
into the pET100/D-TOPO® vector. The PCR product was diluted 1:25 in
nuclease free water and 3L of this product was added to 1L of dilute salt
solution, 1L of water, and 1L of linearized vector. Both the ligation reaction
and transformation into E. coli TOP10 cells were carried out according to the
protocols listed above. Two different sets of PCR primers (Table 2) were used to
identify colonies containing BCcalY-pET100D. Sequencing analysis of each
recombinant plasmid was performed at SeqWright DNA Technology Services
(Houston, TX) using a forward primer (Table 2) specific for the vector, and a
reverse primer specific for the inserted camelysin gene.
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Plasmid Isolation and Analysis of Recombinant Clones
Plasmid isolation was performed using the FastPlasmid™ Mini kit from
Eppendorf (Westbury, NY). E. coli TOP10 cells containing the recombinant
plasmids were grown in LB-AMP for 15 hours in a shaking incubator at 37ºC to
an OD600 of 2.4. 1.5L of each culture was removed and were centrifuged at
15,000 x g for 1 minute. The supernatant was removed and 400L of the lysis
solution, containing RNase A and lysozyme was added to the pellet. The pellet
was resuspended by vortexing on high speed for approximately 30 seconds,
followed by a 3 minute incubation at room temperature. The lysate was then
transferred to a spin column assembly which was then centrifuged for 1 minute at
15,000 x g. The remaining plasmid DNA contained in the spin column matrix
was washed with 400L of diluted wash buffer and centrifuged for another
minute. Filtrate remaining in the bottom of tube was removed and the spin
column assembly was centrifuged for 1 minute to remove any excess
isopropanol that was introduced with the washing buffer. Next, the spin column
was placed into a collection tube and the DNA was eluted by adding 50L of
buffer containing 10mM Tris-HCl / 0.1mM EDTA, pH 8.5 followed by
centrifugation at 15,000 x g for 1 minute. Plasmid DNA used for transfections
was prepared using the Qiagen Plasmid Midi kit according to the manufacturer’s
protocol.
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Transfection and Expression of BCcalY-pcDNA in HeLa cells
Transient transfections were performed using the following constructs;
BCcalY-pcDNA (pcDNA3.1 with the camelysin gene), calY-pcDNA(-) (pcDNA3.1
without any insert), and pcDNA3.1/V5-His-TOPO/lacZ© (pcDNA3.1 that
contained the ß-galactosidase control). A negative control designated HeLa1
(HeLa cells with no vector) underwent the same treatments as transfected cells
to make sure the lipid had no toxic effects on the cells. Prior to transfection the
HeLa cells were plated in a 12-well plate at a cell density of approximately 7.8 x
104 cells per well and were incubated overnight at 37ºC in 5% CO2 until mostly
confluent (~90-100%). The following day, plasmid DNA obtained from the Midi
preps was diluted at a ratio of 1.6g of DNA per 100L of Opti-MEM (Invitrogen)
and the Lipofectamine™ 2000 (Invitrogen) reagent was diluted at a ratio of 4L
lipid per 100L of Opti-MEM according to the manufacturer’s protocol. The
diluted DNA/Lipid mixtures were combined and incubated at room temperature
for 20 minutes. The growth medium was then removed and the entire plate was
washed with PBS, then 1mL of EMEM without 10% FBS was added to each well.
Next, 200L DNA/Lipid mixture was added to each well and the plates were
incubated for 4.5 hours at 37ºC in 5% CO2. The growth media then was
removed and replaced with fresh EMEM containing 10% FBS and the
transfection reaction was allowed to continue for 24 hours. The next day, the
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cells were detached from their respective plates using sterile cell scrapers and
transferred to microcentrifuge tubes. After spinning down the cells, both the
pellet and supernatant were frozen at -20ºC for western blotting analysis, SDSPAGE, and an azocasein enzyme assay.

Expression of BAcalY-pBAD and BCcalY-pBAD and in E. coli TOP10 Cells
The pBAD vector in TOP10 cells, containing either the camelysin gene
from B. anthracis (BAcalY-pBAD) or from B. cereus (BCcalY-pBAD) were used to
express the camelysin protease (35). One other construct designated calYpBAD(-) (pBAD with no insert) was also induced during the expression
experiment, along with TOP10 cells containing no vector. All cultures were
grown in 10mL of LB-AMP overnight at 37ºC in a shaking incubator. 7mL of the
cultures containing BAcalY-pBAD and BCcalY-pBAD were added to 70mL of LBAMP, and 2mL of cultures containing calY-pBAD(-) and TOP10 cells were added
to 20mL of LB-AMP. All cultures were grown for approximately 2 hours to an
OD600 of ~0.75 and then induced with various concentrations of arabinose before
a 4 hour incubation at 30ºC. At the end of the induction, 5L of each sample was
removed to obtain their respective OD600. Finally, the samples were centrifuged
and the supernatant was transferred to a fresh tube, then both the supernatant
and pellet from each culture were frozen at -20ºC for future analysis.
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Expression of BCcalY-pET100D in E. coli BL21 Star™ (DE3)pLysS Cells
The pET vector containing the camelysin gene from B. cereus (BCcalYpET100D) was obtained from the TOP10 cells using the plasmid miniprep kit as
mentioned above. BL21 Star™ (DE3)pLysS cells were transformed with 10ng of
BCcalY-pET100D in a volume of 3L using the heat shock method described
previously and the transformed bacteria, along with untransformed bacteria (as a
negative control) were incubated in 10mL of LB-AMP overnight at 37ºC in a
shaking incubator. Next, 20mL of LB-AMP was inoculated with 2mL of the
overnight culture and was incubated under the same conditions as above for 1
hour and 20 minutes to an OD600 of 0.7. The cultures were then split into two
tubes (10mL in each), one containing 1mM isopropyl ß-D thiogalactoside (IPTG),
for induction of expression, and one without IPTG. At each hour, 500L of each
culture was removed. Once removed, the samples were centrifuged and the
supernatant was transferred to a fresh tube, then both the supernatant and pellet
from each culture was frozen at -20ºC for future analysis.

SDS-PAGE
The cell pellets were resuspended in 1X SDS-Page Sample Buffer
(Invitrogen) and the mixture was boiled for 5 minutes. Next, 20L of each
sample was loaded into a 12% SDS-PAGE gel which underwent electrophoresis
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at 200V for 45 minutes using the Mini-Protean II Electrophoresis Cell (Bio-Rad).
After the electrophoresis was complete, the gel was stained with 0.1%
coomassie blue R-250 (in 40% MeOH / 10%HOAc) for 30 minutes. The gel was
destained with several changes of 40% MeOH / 10%HOAc with a total incubation
time of 2 hours.

Western Blotting Analysis
Following separation by SDS-PAGE, the proteins were transferred to a
nitrocellulose membrane using a Mini Trans-Blot® electrophoretic transfer cell
(Bio-Rad) overnight at 30V/100mA. Next, the membrane was placed in a
blocking solution (TBST with 5% dry milk) for 25 minutes. The primary antibody
(rabbit-anticamelysin) was diluted 1:5,000 in 5mL of blocking solution and the
membrane was incubated for 45 minutes at room temperature (14). The
membrane was washed three times with 20mL of TBST (TBS with 0.05% Tween
20), 8 minute incubations were carried out for each wash. The secondary
antibody, anti-rabbit IgG-Alkaline phosphatase (Sigma) was diluted 1:20,000 in
blocking buffer and the washed membrane was incubated for 45 minutes,
followed by three more washes in TBST. Next, the membrane was placed into
10mL of TBS (0.1M NaCl, 0.5M Tris, pH 7.4) for rinsing

Azocasein Assay
An azocasein assay was used to measure the proteolytic activity of the
recombinant camelysin proteins using standard methods (30, 41). Equal
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volumes of the cell pellets were resuspended in 1mL of 50mM Tris-HCl, pH 7.4
using a pipet. After resuspension the cells were subjected to freezing and
thawing in order to lyse the cells, alternating between a dry ice/ethanol bath and
a 50ºC water bath. The lysate was then subjected to sonication at 100W, 4 times
at 20 second intervals in an ice bath. Next, the lysate was centrifuged for 10
minutes at 12,000 x g and 4ºC for 10 minutes. The supernatant was removed
and the pellets from each sample were resuspended in 400L of 50mM Tris-HCl,
pH 7.4. Then, 200L of each sample were separately added to tubes containing
200L of the azocasein substrate solution (5mg/mL azocasein resuspended in
50mM Tris-HCl, pH 7.4) and incubated at 37ºC for 16 hours. The proteolytic
activity was stopped with the addition of 800L of 10% trichloroacetic acid (TCA),
which also precipitates any undigested azocasein. The samples were
centrifuged at 12,000 x g for 4 minutes and 1mL of the supernatant was
transferred to a cuvette. The samples were placed in a SmartSpec Plus
spectrophotometer (Bio-Rad) and the OD365 for each sample was recorded.

Beta Galactosidase Control Assay
The HeLa cell pellets were washed twice with 1X PBS, pH 7.4 (Mg2+/Ca2+
free) and resuspended in TEN buffer (40mM Tris-HCl, pH 7.5, 1mM EDTA, pH
8.0, and 150mM NaCl). The cell suspension was centrifuged at 18,000 x g for 1
minute at 4ºC, resuspended in 0.25M Tris-HCl (pH 8.0), and subjected to 3
freeze thaw cycles by alternating between dry ice/ethanol and a 37ºC water bath.
The lysate was then centrifuged at 18,000 x g for 2 minutes at 4ºC and the
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supernatant was assayed. A 96 well plate was loaded with 50L samples from
each transfection reaction, either diluted (1:10) or undiluted. Next, 50L of assay
buffer (200mM sodium phosphate buffer, pH 7.3, 2mM MgCl2, 100mM ßmercaptoethanol, 1.33mg/mL ONPG) was added to each well, mixed by
pipetting, and incubated at 37ºC for 50 minutes. At the end of the incubation, the
plate was visually observed for color change and 150L of 1M sodium carbonate
was added to each well to stop the reaction.
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RESULTS
Amplification of calY by PCR and Cloning into the pcDNA3.1/V5-His©
TOPO® TA Expression Vector
Due to the fact the proteases mode of toxicity is not known, this study
used the eukaryotic expression vector pcDNA3.1 first to examine if mammalian
expression was possible, and secondly to observe any intracellular protease
activity, like the lethal factor of B. anthracis. After isolation of the genomic DNA
from B. cereus, camelysin gene (calY) was amplified by PCR. Primers were
designed to amplify the 594 bp gene using the genomic DNA sequence of B.
cereus ATCC 14579 obtained at the NCBI website, gene ID # 1203630 (Table 2).
Due to the fact that pcDNA3.1/V5-His© TOPO® TA is a eukaryotic expression
vector, the start codon (ATG) was incorporated into the forward primer. This
allowed correct translational recognition by the mammalian cells ribosome’s (17).
This vector also has a cytomegalovirus (CMV) promoter that allows for
overexpression of proteins once transfected into mammalian cells. Agarose gel
electrophoresis was performed and confirmed the successful amplification of
calY (Figure 1). Next, calY was ligated into the pcDNA3.1/V5-His© TOPO® TA
expression vector and was transformed into E. coli TOP10 cells. Ligation into
TOPO TA vectors employs the use of deoxyadenosines left on the 3 ends of
PCR products by Taq polymerase which allowed the amplified DNA to bind to the
23

3 deoxythymidines located on the linearized vector. The vector is kept in a
linearized form before the insertion of amplified DNA by topoisomerase I that
cleaves one strand of the vectors DNA after the sequence 5-CCCTT, which is
located at the cloning site. The energy of this broken bond was conserved by a
covalent bond between the 3 phosphate of the vector DNA and a tyrosyl residue
of the topoisomerase I. The energy was released and the bond was broken
when the newly inserted DNA was introduced at the cloning site, which in turn
released the topoisomerase and allowed the formation of the double stranded
recombinant vector (Figure 2).

Table 2. PCR primers used for amplification of genomic DNA and confirmation of
gene insertion.
Primer
name
pBAD
calY
forward
pcDNA
calY
forward
pET calY
forward

Primer sequence

DNA amplified

Vector used

AGTCTGAAAAAGAAATTAGGTATGG
GGAGT

pBAD

pBAD
forward
T7 forward

ATGCCATAGCATTTTTATCC

Genomic DNA from B. anthracis
and B. cereus without the native
GTG start codon.
Genomic DNA from B. cereus
with ATG added for mammalian
expression system.
Genomic DNA from B. cereus
containing CACC needed for
insertion into vector.
Vector DNA, used to confirm the
insertion of calY.
Vector DNA, used to confirm the
insertion of calY.
Genomic DNA from B. cereus
containing the native stop codon.

TTATTTTTCTTCCCCAGCTTCTTGGT
T

Genomic DNA from B. cereus
containing the native stop codon.

pcDNA3.1

TTATTTTTCTTCTCCAGCTTCTTG

Genomic DNA from B. anthracis
containing the native stop codon.

pBAD

GATTTAATCTGTATCAGG

Vector DNA, used to confirm the
insertion of calY.
Vector DNA, used to confirm the
insertion of calY.

pBAD

Native
calY
reverse
pcDNA
calY
reverse
pBAD BAcalY
reverse
pBAD
reverse
T7 reverse

ATGGTGAGTCTGAAAAAGAAATTAG
GTTATGGGAGT
CACCGTGAGTCTGAAAAAGAAATTA

TAATACGACTCACTATAGGG
TTATTTTTCTTCCCCAGCTTCTTG

TAGTTATTGCTCAGCGGTGG
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pcDNA3.1

pET100/D

pBAD
pcDNA3.1 &
pET100/D
pET100/D &
pBAD

pET100/D

Figure 1. PCR amplification of the 594 bp camelysin gene (3 additional
nucleotides for the mammalian start codon ATG) from B. cereus ATCC 14579
using primers pcDNA calY forward and pcDNA calY reverse. The 1% agarose
gel confirms the presence of the 594 bp DNA fragment. Lane 1: 100 bp ladder
and Lane 2: amplified calY from genomic DNA.

Figure 2. Map of the mammalian expression vector pcDNA3.1/V5-His© TOPO®
TA containing calY with the mammalian start codon ATG. The stop codon, TAA
was used to end translation and allowed the overexpression of the native protein
without any fusion tags. Ampicillin was used to screen for positive clones.
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Confirmation of the Successful Cloning into pcDNA3.1/V5-His© TOPO® TA
Following the amplification and ligation of calY into the expression vector,
the vector was used to transform E. coli TOP10 cells and was propagated.
Plasmid DNA was then isolated from eight colonies and screened for correct
insertion of calY into the vector by PCR analysis (Figure 3), restriction enzyme
digestion with BstX I (Figure 4), and then DNA sequencing. PCR amplification
was carried out using 100ng of the calY-pcDNA as a template and the primers T7
forward / pcDNA calY reverse. The products were subjected to agarose gel
electrophoresis and the 668 bp fragment confirmed that both the ligation into the
vector and the insertion of calY in the correct orientation was successful.
Restriction digestion was carried out on the recombinant plasmid and yielded two
bands, the first representing the plasmid (6120 bp) and the second representing
the insert with some excess vector nucleotides (638 bp), confirming the cloning
was successful. DNA sequencing was performed at the H. Lee Moffitt Cancer
Center’s Molecular Biology Core Facility. Once the sequence information was
obtained a BLAST2seq (39) was performed against the original gene sequence
from B. cereus ATCC 14579’s calY, confirming no mutations were introduced
during the cloning process.
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Figure 3. PCR amplification products on a 1% agarose gel used for identifying
correct insertion of calY. Lane 1: 100 bp ladder, Lane 2: 323 bp PCR control,
and Lanes 3-10 are recombinant plasmid amplified using the primers T7 forward
/ pcDNA calY reverse to give the 668 bp product. This represented a 63%
cloning efficiency.

Figure 4. Restriction enzyme analysis on a 1% agarose gel using BstX I after
incubation at 50ºC. Lane 1: 100 bp ladder, Lane 2:  Hind III ladder, Lane 3: 1hr
incubation with BstX I, Lane 4: 1hr incubation without BstX I, Lane 5: 2hr
incubation with BstX I, Lane 6: 2hr incubation without BstX I, Lane 7: 3hr
incubation with BstX I, Lane 8: 3hr incubation without BstX I, Lane 9: 4hr
incubation with BstX I, Lane 10: 4hr incubation without BstX I, Lane 11: 5hr
incubation with BstX I, Lane 12: 5 hr incubation without BstX I. Uncut plasmid is
6120 bp in size, cut plasmid has two distinct bands, one 5482 bp and the other
638 bp.
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Transfection into HeLa cells and Expression of BCcalY-pcDNA
After obtaining large amounts of the recombinant plasmid using a MidiPrep Kit, BCcalY-pcDNA (pcDNA3.1 with the camelysin gene), calY-pcDNA (-)
(pcDNA3.1 without any insert), and pcDNA3.1/V5-His-TOPO/lacZ© (pcDNA3.1
that contained the ß-galactosidase control) were transiently transfected into HeLa
cells. The HeLa cells appeared to be confluent both before and after transfection
in all cultures, as did a culture containing only HeLa cells that underwent the
same lipid and medium treatments as transfected cells. SDS-PAGE was
performed on each of the cell cultures and no differences in banding patterns
were observed except for the 122 kDa band present for the ß-galactosidase
control. Western blotting, an azocasein assay, and immunoblotting were also
performed on each culture and all results were negative. To test the positive
control for ß-galactosidase activity, a ß-galactosidase assay was performed and
demonstrated that not only did the transfection work, but it also produced the
active ß-galactosidase protein (Figure 5).
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Figure 5. ß-galactosidase Assay demonstrating the production of ßgalactosidase. Well 1 (A,B,C): pcDNA3.1/V5-His-TOPO/lacZ©, Well 2(A,B,C):
pcDNA3.1/V5-His-TOPO/lacZ© diluted 1:10, Well 3(A,B,C): calY-pcDNA (-), Well
4(A,B,C): calY-pcDNA (-) diluted 1:10, Well 5(A,B,C): BCcalY-pcDNA, Well
6(A,B,C): BCcalY-pcDNA diluted 1:10, Well 7(A,B,C): HeLa cells, Well 8(A,B,C):
HeLa cells diluted 1:10.
Amplification of calY by PCR and Cloning into the pBAD TOPO® TA
Expression Vector
Genomic DNA containing the camelysin gene from both B. anthracis and
B. cereus was amplified by PCR using the Expand Long Template PCR system
for insertion into the pBAD TOPO® TA vector (Figure 6) to examine if prokaryotic
expression was possible without the generation of a fusio tagged protein. This
system contains a mixture of two polymerases (Taq and Tgo) that gave a high
yield of PCR product that was proofread via the Tgo polymerases 3’-5’
exonuclease activity. The pBAD vector is advantageous for use in expressing
suspected toxic proteins as it contains the tightly regulated araBAD promoter,
which controls the level of protein expression. Another advantage to using this
vector system is the fact that it contains a short N-terminal leader peptide, which
improved translation of the protein and also increased its solubility (42). The
vector also allows a V-5 epitope and a polyhistidine tag to be placed at the C29

terminal end of a recombinant protein, which could prove useful for detecting a
fusion protein. However, in this experiment the tags were left out since we
already had the antibody for purified camelysin and the tags cannot be cleaved
off once placed onto the native protein. The genomic DNA sequence for the B.
anthracis camelysin gene was obtained from the NCBI website (39), protein ID #
AAP25246.1. The start codon was removed from the forward primer since the
vector contains its own initiation codon, and the stop codon was left to prevent
formation of a fusion tagged protein. The PCR product was obtained and then
ligated into the TA vector as previously described (Figure 7). Following ligation,
E. coli TOP10 cells were transformed with the recombinant vector and grown in
LB-AMP to propagate the plasmid.

Figure 6. PCR amplification of calY from B. anthracis using primers pBAD calY
forward / pBAD BA-calY reverse and from B. cereus using primers pBAD calY
forward / Native calY reverse for cloning into pBAD TOPO® TA. The 1% gel
confirms the presence of the 591 bp camelysin gene (no start codon on primer).
Lane 1: 1kb ladder, Lanes 2-3: B. anthracis calY, and Lanes 4-5: B. cereus calY.
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Figure 7. Map of the prokaryotic expression vector pBAD TOPO® TA containing
calY without its own start codon, GTG. The stop codon, TAA was used to end
translation to allow expression of the native protein without any fusion tags.
Ampicillin was used to screen for positive clones once transformed into E. coli
TOP10 cells.
Confirmation of the Successful Cloning into pBAD TOPO® TA
The products obtained by PCR amplification of calY from B. anthracis and
B. cereus were ligated into the pBAD vector and used to transform TOP10 cells,
recombinant plasmid was then isolated from five colonies using Mini-Preps. The
recombinant plasmid was then screened for correct insertion of calY into the
vector by PCR analysis (Figures 8Aand 8B), and DNA sequencing. PCR
amplification was carried out using approximately 100ng of BAcalY-pBAD and
BCcalY-pBAD as templates and the primers for both the camelysin gene and the
vector. The products were subjected to agarose gel electrophoresis and the
distinct bands at 594 bp and 773 bp confirmed that both the ligation into the
vector and the insertion of calY in the correct orientation were successful.
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Figure 8A. PCR amplification products on a 1% agarose gel used for identifying
the correct insertion of BAcalY and BCcalY into the pBAD vector. Lane 1: 1kb
ladder, Lanes 2-6: PCR of BAcalY using pBAD calY forward / pBAD BA-calY
reverse, Lane 7: Empty well, and Lanes 8-12: PCR of BAcalY using pBAD
forward / pBAD BA-calY reverse. This represented a 60% cloning efficiency.

Figure 8B. PCR amplification products on a 1% agarose gel used for identifying
the correct insertion of BAcalY and BCcalY into the pBAD vector. Lane 1: 1kb
ladder, Lanes 2-6: PCR of BCcalY using pBAD calY forward / Native calY
reverse, Lane 7: 1kb ladder, Lane 8: Empty well, and Lanes 9-13: PCR of
BCcalY using pBAD forward / Native calY reverse. This represented a 40%
cloning efficiency.
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DNA sequencing was performed at SeqWright DNA Technologies
(Houston, TX). Once the sequence information was obtained a BLAST2seq (39)
was performed against the original gene sequences from both B. anthracis and
B. cereus ATCC 14579’s calY, confirming no mutations were introduced during
the cloning process.

Expression of BAcalY-pBAD and BCcalY-pBAD
Expression of BAcalY-pBAD and BCcalY-pBAD was induced in E. coli
TOP10 cells by using different concentrations of arabinose to identify the amount
needed for successful expression of the protease. The induced culture was
incubated at 30ºC in a shaking incubator for 4 hours. At the end of the 4 hours,
the OD600 was recorded for each culture and the averages were 2.4 for BAcalYpBAD, 2.2 for BCcalY-pBAD, and 3.1 for E. coli TOP10 with no vector. The lower
values for BAcalY-pBAD and BCcalY-pBAD indicate the possible presence of
toxicity in the cells expressing camelysin. SDS-PAGE was performed on each of
the samples and the 19 kDa mature camelysin protein was observed for both the
B. anthracis and B. cereus constructs (Figures 9 and 10 respectively). The
greatest amount of protein seemed to be produced when each induced sample
had arabinose at a final concentration of 0.002%.
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Figure 9. Expression of calY from BAcalY-pBAD construct. Lane 1: MW marker,
Lane 2: uninduced BAcalY-pBAD, Lanes 3-7: BAcalY-pBAD induced with 0.2%,
0.02%, 0.002%, 0.0002%, and 0.00002% arabinose respectively, Lane 8: pBAD
vector with no insert induced with 0.2% arabinose, and Lane 9: E. coli TOP10
cells with no vector induced with 0.2% arabinose. The camelysin protein (~19
kDa) can be seen in lanes 3-7, however the strongest bands are in lanes 5 and
6.

Figure 10. Expression of calY from BCcalY-pBAD construct. Expression of calY
from BCcalY-pBAD construct. Lane 1: MW marker, Lane 2: empty well, Lane 3:
uninduced BCcalY-pBAD, Lanes 4-8: BCcalY-pBAD induced with 0.2%, 0.02%,
0.002%, 0.0002%, and 0.00002% arabinose respectively, Lane 9: pBAD vector
with no insert induced with 0.2% arabinose, and Lane 10: E. coli TOP10 cells
with no vector induced with 0.2% arabinose. The camelysin protein (~19 kDa)
can be seen in lanes 4-8, however the strongest bands are in lanes 6 and 7.
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Amplification of calY by PCR and Cloning into the pET100/D-TOPO®
Expression Vector
DNA from B. cereus ATCC 14579 was amplified by PCR using the
PfuTurbo® DNA polymerase for integration into pET100/D-TOPO® (Figure 11) to
examine if the creation of a fusion tagged protein would effect expression levels
of camelysin. The Pfu polymerase contains 3’-5’ exonuclease activity much like
the Tgo polymerase used for cloning into the pBAD system. However, the Pfu
polymerase does not add any deoxyadenosines onto the PCR product because it
lacks this activity, which leaves the PCR products with blunt ends. Ligation of the
PCR product into this TOPO vector required the sequence CACC to be added
onto the forward primer of camelysin. The linearized vector contains a region
complimentary to this sequence, thus allowing directional binding of the PCR
product to the vector that is also in frame with the other genes on the vector.
Primers were designed with the CACC located in the forward primer (pcDNA
calY forward) without a stop codon following the sequence that allowed
expression of a fusion protein containing the N-terminal polyhistidine tag and
X™press epitope, while the reverse primer (Native calY reverse) contained
camelysin’s native stop codon (Figure 12). Once the PCR product was obtained,
it was ligated into the vector and transformed into E. coli TOP10 cells for
propagation.
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Figure 11. PCR amplification of the 598 bp camelysin gene (4 additional
nucleotides for the addition of CACC) from B. cereus ATCC 14579. The 1%
agarose gel confirms the presence of the 598 bp DNA fragment. Lane 1: 1kb
plus ladder and Lane 2: amplified calY from genomic DNA.

Figure 12. Map of the prokaryotic expression vector pET100/D-TOPO®
containing the native calY with the addition of CACC at the 5 end. The stop
codon, TAA was used to end translation and ampicillin was used to screen for
positive clones once transformed into E. coli TOP10 cells.
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Confirmation of the Successful Cloning into pET100/D-TOPO®
Plasmid DNA from five E. coli clones were obtained and screened for the
presence of the camelysin gene using PCR (Figures 13A and 13B) and DNA
sequencing. The plasmid DNA containing the camelysin gene was PCR
amplified using the primers sets T7 forward / Native calY reverse and pET calY
forward / T7 reverse yielding fragments of 794 bp and 679 bp respectively,
confirming that camelysin was inserted into the vector.

Figure 13A. PCR amplification products on a 1% agarose gel used for identifying
the correct insertion of BCcalY into the pET vector. Lane 1: 1kb plus ladder and
Lanes 2-6: PCR of BCcalY-pET100D using T7 forward / Native calY reverse.
This represented a 20% cloning efficiency.
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Figure 13B. PCR amplification products on a 1% agarose gel used for identifying
the correct insertion of BCcalY into the pET vector. Lane 1: 1kb, plus ladder and
Lanes 2-6: PCR of BCcalY-pET100D using pET calY forward / T7 reverse.

DNA sequencing on BCcalY-pET100D was performed at SeqWright DNA
Technologies (Houston, TX). Once the sequence information was obtained a
BLAST2seq (39) was performed against the original gene sequences from B.
cereus ATCC 14579’s calY, confirming no mutations were introduced during the
cloning process and that the gene was inserted into the TOPO vector. The
vector was then transformed into E. coli BL21 Star™ (DE3)pLysS for expression.
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Expression of BCcalY-pET100D
The vector contains a T7lac promoter that was induced by production of
T7 RNA polymerase in the host cells and a lac operator that the lacI repressor
protein (expressed in the BL21 cells) binds, thus decreasing the chances of basal
expression. E. coli BL21 Star™ (DE3)pLysS cells have the lambda DE3 lysogen
which has the gene for the T7 RNA polymerase and is tightly regulated by the
lacUV5 promoter in the cells chromosome. IPTG was used to turn on the lacUV5
promoter, which resulted in overexpression of the protein encoded by the PCR
product that was inserted into the pET vectors cloning site. Since
overexpression can be a problem with toxic proteins, the BL21 Star™
(DE3)pLysS strain were used to express camelysin since they also produce a T7
lysozyme that slowed expression by binding to T7 RNA polymerase and
inactivating it. The BL21 cells transformed with BCcalY-pET100D were induced
with IPTG for 4 hours. After each hour, samples were taken and stored for
further analysis. SDS-PAGE was performed on the all of the samples (Figure
14), and no noticeable differences were apparent upon staining with Coomassie
blue.
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Figure 14. Expression of BCcalY-pET100D in BL21 Star™ (DE3)pLysS cells. No
banding pattern differences were discernable.
Lanes 1 & 11: MW marker, Lane 2: Induced BL21 Star™ (DE3)pLysS cells,
Lanes 3, 5, 7, & 9: Uninduced BL21 cells at 1, 2, 3, and 4 hours respectively,
Lanes 4, 6, 8, & 10: Induced BL21 cells at 1, 2, 3, and 4 hours respectively.

Western Blotting Analysis
After performing SDS-PAGE on samples from each vector system, a
Western blot was performed and confirmed that the protein bands that were
apparent on some of the gels were indeed that of camelysin (Figure 15). Despite
not seeing any noticeable bands on the SDS-PAGE performed on the BCcalYpET100D expression, two bands were apparent in the samples that were
induced with IPTG for 3 hr and 4 hr. These bands were located around 65 kDa
and the purple color is indicative of a positive reaction, while the brown colored
bands are negative. The 19 kDa bands seen on the SDS-PAGE from the
BAcalY-pBAD and BCcalY-pBAD expression were apparent on the Western blot
at the same location, thus indicating successful expression in both the pET and
pBAD vector systems.
40

Figure 15. Western blotting analysis of camelysin expressed in the pBAD and
pET vector systems. Lane 1: BCcalY-pET100D after 3 hr induction, Lane 2:
BCcalY-pET100D after 4hr induction, Lane 3: BAcalY-pBAD induced with
0.002% arabinose, and Lane 4: BCcalY-pBAD induced with 0.002% arabinose.

Azocasein Assay
To test the proteolytic activity present in all three vector system expression
experiments, an enzyme assay using azocasein as a substrate was performed.
Azocasein is made up of orange sulfanilamide groups that are covalently bound
to the peptide bonds of casein. Once a protease attacks these bonds, small
peptides and sometimes amino acids are released giving the solution a dark
orange color. TCA was added after an overnight incubation at 37ºC, which
precipitated the protease and any undigested azocasein. Following
centrifugation, the small digested particles (giving the orange color) are
contained in the supernatant and the OD365 is read (Figure 16), thus the higher
the OD, the greater the amount of proteolytic activity present. The supernatants
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of BAcalY-pBAD, BCcalY-pBAD, and BCcalY-pET100D appear to have the
highest proteolytic activity indicating the presence of camelysin. The pellets also
contain some activity, but less than the supernatants. Negative controls included
HeLa cells transfected with the pcDNA vector with no insert (calY-pcDNA(-)) and
E. coli TOP10 cells transformed with the pBAD vector with no insert.

Absorbance at 365 nm

Proteolytic Activity of Cells
0.12
0.1
0.08
0.06
0.04
0.02
0
pBAD pBAD pBAD pBAD pcDNA pcDNA pET
BA
BA
BC
BC
HeLa HeLa
BC
pellet sup pellet
sup pellet sup pellet

pET
BC
sup

HeLa
pellet

HeLa Top10 Top10
sup pellet sup

Cells Used

Figure 16. Degradation of azocasein by camelysin. An increase in the OD365
indicated high proteolytic activity in the supernatants of the cells that were
transformed and induced with camelysin using either the pBAD or pET vectors.
Top10 cells transformed with the empty pBAD vector appear to have some
proteolytic activity, but is insignificant when compared to the Top10 cells that
were transformed with either BAcalY-pBAD, BCcalY-pBAD, or BCcalY-pET100D.
HeLa cells transfected with the empty pcDNA vector exhibited minute levels of
proteolytic activity. Error bars indicate the standard deviation from the mean for
each cell type used.

Sequence Analysis of calY in B. anthracis and B. cereus ATCC 14579
A multiple sequence alignment was performed on both the nucleotide
(Figure 18) and amino acid (Figure 17) sequences of calY from B. anthracis and
B. cereus using the GAP alignment tool from the GCG Wisconsin Package®
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software to check for the degree of homology between the two proteins and their
genes. The results of the alignment concluded there is a 94.78% similarity
between the two organism’s nucleotide sequences. Out of the 594 nucleotides in
both camelysin genes, there were 30 differences between the two sequences
(Figure 18). There are 197 amino acids in both camelysin genes; the alignment
identified 9 amino acid differences between the two sequences and concluded
there was a 95.94% similarity between the two amino acid sequences (Figure
17).

Figure 17. Multiple sequence alignment of the amino acid residues for camelysin
from B. anthracis and B. cereus. The first amino acid sequence is that of B.
anthracis and the second is that of B. cereus. The amino acids that are
highlighted in gray indicate a difference between the two proteins. Two dots
between each residue that differs indicates a threshold of 2 for the alignment
score conveying a strong similarity between the two amino acids, and one dot
between each residue indicates a threshold of 1 for the alignment, conveying a
similarity between the two amino acids, but not as high. A blank space between
the residues indicates no similarity between the different amino acid residues.
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Figure 18. Multiple sequence alignment of the nucleotides for camelysin from B.
anthracis and B. cereus. The first nucleotide sequence is that of B. anthracis and
the second is that of B. cereus. The nucleotides that are highlighted in gray
indicate a difference between the two genes.
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Prediction of the Putative Signal Peptide of Camelysin from B. anthracis
and B. cereus ATCC 14579 using Neural Network and Hidden Markov
Models.
Both neural network and hidden Markov models were used to predict
where the putative signal peptide of the camelysin protein is located using the
SignalP 3.0 server (3). Due to the fact this protease exhibits unusual behavior
and has no conserved domains it was imperative to perform several forms of
sequence analysis. The signal peptide analysis allows us to view differences
between the two proteins signal peptides as well as differences in their cleavage
sites. The neural network model calculates where both the predicted signal
peptide and the position of the signal peptidase I cleavage site are located using
two separate networks. The signal peptide was predicted to contain amino acids
1-29 with a cleavage site between residues 29 and 30 for the camelysin protein
of B. anthracis and B. cereus ATCC 14579 (Figures 19A and 19B).
The hidden Markov model calculates whether or not a given amino acid
sequence contains a signal peptide. If the sequence of interest is predicted to
contain a signal peptide the location of the cleavage site, N-terminus, C-terminus,
and alpha-helical segments of the signal peptide are included in the output. The
Markov model predicted the signal peptide to consist of amino acid residues 1-27
with a cleavage site between residues 27 and 28 for the camelysin protein of B.
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anthracis and B. cereus ATCC 14579 (Figures 20A and 20B). The N-terminal
region of the signal peptide was predicted to be comprised of residues 1-6, the
alpha helical region 7-20, and the C-terminal region to be from 21-27 in the
protease from both organisms.

Figures 19A and 19B. SignalP 3.0’s neural network model prediction of the
camelysin protein’s signal peptide. The C score corresponds to the probability
that a particular residue is located at the signal peptidase I site, the S score
reflects the probability that residues are part of the signal peptide, and the Y
score helps to predict the cleavage site at points where the steep slopes of the C
score line are located. Figure A is the sequence from B. anthracis and Figure B
is the sequence from B. cereus. Camelysin from both organisms are predicted to
contain the same signal peptide and are predicted to be secreted.
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Figures 20A and 20B. SignalP 3.0’s hidden Markov model prediction of the
camelysin protein’s signal peptide. The cleavage probability is the location
where cleavage of the signal peptide is most likely to occur; the N-region, Hregion, and C-region probabilities correspond to the predicted N-terminal, alpha
helical, and C-terminal regions of the signal peptide. Figure A is the sequence
from B. anthracis and Figure B is the sequence from B. cereus. Camelysin from
both organisms are predicted to contain the same signal peptide and are
predicted to be secreted.
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Secondary Structure Prediction of Camelysin from B. anthracis and B.
cereus ATCC 14570
The predicted secondary structure of camelysin was obtained from the
PSIPRED Protein Structure Prediction Server (21, 28). A multiple sequence
alignment was performed using the GAP alignment tool from the GCG Wisconsin
Package® software to identify similar structural characteristics between the two
peptides from B. anthracis and B. cereus ATCC 14579 (Figure 21). The
alignment revealed that the secondary structure between the two proteins is
95.94% similar. The alpha helical region of the predicted signal peptide is also
apparent in this secondary structure analysis, however there are also two other
helical regions, possibly involved with anchoring the protein to the membrane of
the cell (Figures 22 and 23).

Figure 21. Secondary structure comparison between camelysin from B. cereus
and B. anthracis. Out of the 197 peptides, only 4 peptides exhibited different
secondary structure characteristics between the two peptide strands (gray
residues). C, E, and H correspond to coil, strand, and helix respectively.
48

Figure 22. Secondary structure prediction of camelysin from B. anthracis using
PSIPRED. The protein is predicted to contain 4 alpha helices and 12 strands.
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Figure 23. Secondary structure prediction of camelysin from B. cereus using
PSIPRED. The protein is predicted to contain 4 alpha helices and 12 strands,
identical to the prediction for the proteins secondary structural characteristics for
B. anthracis.
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DISCUSSION
The focus of this study was aimed at identifying, cloning, and expressing
the active camelysin protease from B. cereus ATCC 14579 and B. anthracis.
Previous studies demonstrated that camelysin isolated from an uncharacterized,
unsequenced strain of B. cereus may play a role in the pathogenicity of this
organism, which is why B. cereus ATCC 14579 was chosen. Blastn and blastp
searches revealed a putative camelysin gene may also be located in B.
anthracis. These findings along with the fact that B. anthracis is such a potent
pathogen were the reasons why it was chosen for this study. Identifying a
suitable method for obtaining large amounts of this highly hydrophobic
membrane protease was another goal of this project due to the difficulty in
obtaining even minute amounts of the protease from the native organism and
also due to the dangers of culturing live B. anthracis. Obtaining large amounts of
the camelysin protease, with or without a fusion tag will allow future studies to be
performed that are focused on the delineation of camelysin’s possible role in the
pathogenicity of these organisms.
The camelysin gene from B. cereus ATCC 14579 was first cloned into the
mammalian expression vector pcDNA3.1/V5-His© TOPO® TA. Several proteins
are linked to pathogenicity by causing damage intracellularly, like the lethal factor
of B. anthracis. A mammalian expression vector was used to see if it would be
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possible to express the protease intracellularly in a mammalian cell line to
observe any possible pathogenic effects of the enzyme. This would allow
intracellular studies of camelysin’s involvement in pathogenicity without
purification of the protease, reconstitution into liposome’s, and then adding the
protein to a cell culture. PCR, restriction digestion analysis, and DNA
sequencing confirmed that BCcalY was successfully inserted into the vector.
Plasmid was obtained by performing large scale plasmid isolation from the
transformed TOP10 cells and the DNA electrophoresis confirmed the purity of the
recombinant plasmid. HeLa cells were grown to confluency and the recombinant
vector was transiently transfected into the cells. Unfortunately there was no
expression of the camelysin protein as indicated by SDS-PAGE, western blotting,
immunoblotting analysis, and an azocasein assay. To make sure there were no
errors with the transfection, the positive control pcDNA3.1/V5-His-TOPO/lacZ©
(pcDNA3.1 that contained the ß-galactosidase control) was transfected into the
same HeLa cell cultures during the expression experiment. The IPTG assay
(Figure 5) demonstrated that there was ß-galactosidase activity, indicating there
were no problems with the transfection methodology.
There are several possible explanations for the mammalian expression
failure. Mammalian systems often do not process or fold heterologous proteins
properly because of different translational and post-translational machinery. The
mature camelysin protein exhibits self aggregation and is extremely hydrophobic
most probably due to oligomerization (13). These characteristics are only
exhibited in the properly folded protein; if camelysin is not properly folded it could
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be recognized by intracellular proteases which would destroy any camelysin
protein produced immediately after translation. In addition, bacterial membrane
proteases often need specific bacterial transport systems, like the Sec pathway
for crossing and integrating into the membrane of the cells; in HeLa cells these
pathways are not present. HeLa cell membranes also contain a much different
phospholipid environment than the ones found in prokaryotic cell membranes.
Direct membrane insertion of membrane bound proteases is often based on
phospholipid composition (15).
Following the expression trial in the mammalian system, the camelysin
gene was cloned into the pET100/D-TOPO®, vector. The pET vector has several
advantages over pcDNA3.1/V5-His© TOPO® TA. There are two N-terminal fusion
tags, a histidine tag and an X™press epitope which can be used for purification
or detection of a fusion protein and both can be removed using enterokinase, due
to the presence of an enterokinase cleave site located C-terminal to the tags.
After successful PCR amplification the gene was inserted into the vector and
transformed into the TOP10 cells. PCR and DNA sequencing confirmed that
BCcalY was successfully inserted into the vector.
Mini-preps were performed on the TOP10 cells and the vector was
transformed into E. coli BL21 Star™ (DE3)pLysS cells. Once induced with IPTG,
the cells expressed the recombinant protease in a controlled manner. SDSPAGE was unable to demonstrate the successful expression of camelysin once
stained with coomassie blue. This is not unusual since previous studies have
shown (13) that camelysin in its mature state forms hydrophobic aggregates that
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do not stain with coomassie blue. However, western blot analysis detected a
positive result with band at 65 kDa, similar to the molecular weight obtained of
aggregated camelysin on SDS-PAGE gels that were stained with colloidal gold in
previous studies (15). In addition to the positive results obtained for the western
blot, the protein also exhibited proteolytic activity using an azocasein assay
(Figure 16), indicative of the presence of camelysin in its active form.
Next, the camelysin gene from B. anthracis and B. cereus was cloned into
the pBAD TOPO® TA expression vector. The camelysin gene from B. anthracis
was only cloned into this vector due to the difficulty in obtaining the genomic
DNA. This allowed us to examine the expression of camelysin from both
organisms using an expression vector designed especially for producing toxic
proteins. Additionally, this vector contains an N-terminal leader peptide that is
shown to increase the solubility of recombinant proteins. The C-terminal histidine
tag and V-5 epitope were purposely left out of the recombinant protein since they
can not be removed from the protein after purification, and their effects on the
enzymatic activity were not known at the time. Once inserted into the vector, it
was transformed into TOP10 cells and confirmation of the genes correct
orientation and sequence was accomplished by PCR and DNA sequencing.
The recombinant clones expressed camelysin after induction using
various concentrations of arabinose. SDS-PAGE confirmed the expression of
the mature, non-aggregated 19 kDa protease after staining with coomassie blue.
There are many possible explanations for the difference in molecular weight
between expressions, the first being the presence of fusion tags on the protease
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of the pET vectors product. By adding the tags, the protease may have taken on
a more native and aggregated form as seen in previous studies, which does not
stain well when coomassie blue is used. The hydrophobic aggregation of this
protease makes it difficult for it to travel through SDS-PAGE gels even after using
reducing conditions (13). The proteins expressed in the pBAD system, lacked
these fusion tags and also contained a leader peptide which increases the
solubility of most the proteins that are expressed, which would explain the
different results on SDS-PAGE between the pBAD and pET systems. A western
blot performed on both the BAcalY-pBAD and BCcalY-pBAD recombinant
proteins demonstrated a positive result which included a band at 19 kDa, backing
up the SDS-PAGE analysis. An azocasein assay was performed on the two
recombinant proteins following the western blot, and both demonstrated
proteolytic activity, consistent with the active native protease obtained from B.
cereus and the pET vectors recombinant protease.
Various methods of sequence analysis were performed on the camelysin
gene and protein from both B. cereus ATCC 14579 and B. anthracis Ames strain.
The first analysis included a multiple sequence alignment which demonstrated
the high similarity between the two sequences at both the nucleotide and amino
acid level. Since camelysin from B. cereus is shown to have properties
suggesting it may be involved in pathogenesis, it gave reason to clone the gene
from both organisms. Signal peptide analysis using SignalP 3.0 allowed
prediction of the position of the signal peptide, its cleavage site, and whether or
not the peptide is soluble or insoluble. The mature protein was show to have 2
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different predicted sites of cleavage, probably due to the different models used,
the first site was between amino acid residues 29 and 30 and the other was
between amino acids 27 and 28, the latter was previously reported as the
putative site in another paper (16).
Secondary structure analysis was performed using PSIPRED. Results of
the structure analysis further strengthened the possibility that the signal peptide
of camelysin was located within the first 30 amino acids. Previous studies on
camelysin suggest this location due to the fact that signal peptides usually have
basic amino acids in the N-terminus, followed by a hydrophobic section of amino
acids (usually represented by helical secondary structures), and Gly residues at
the C-terminus (16, 25, 30, 33). The PSIPRED prediction found two more
possible alpha helices not previously described that could be involved in with the
hydrophobic interactions that keep camelysin associated to the cell membrane.
Grass, et al, have already demonstrated that camelysin is neither bound to the
cell membrane by electrostatic interactions (camelysin was not removed from cell
membrane after washing under high salt conditions and after using enzymes that
cause lysis), transmembrane stretches of hydrophobic amino acids (which is only
found in the N-terminal signal peptide), the modifications of lipoproteins (the
recognition domain for the lipoprotein signal peptidase is not present in
camelysin), or covalent linkages (molecular mass of protein matches well with
predicted molecular mass from sequence) (16). The two new alpha helices
seem to exhibit amphipathic properties (data not shown) from a hydrophobicity
prediction performed in the Clone Manager software (Science and Educational
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Software, Inc. Cary, NC.). These amphipathic alpha helices are one possible
way that the protease may bind to the cell membrane and they fall within one of
the six hydrophobic domains found using the DAS transmembrane server (8)
identified in previous studies (Grass 2004).
This study indeed proves that the camelysin gene is found both in B.
cereus and B. anthracis, and that the active protease, although only weakly
proteolytic, can be expressed in gram negative prokaryotic expression systems.
This will prove extremely useful in the future as this system, or newer gram
positive vector systems can be used to create knock-out clones to identify the
active region of the camelysin protein (9). Due to the fact that camelysin was
found in B. anthracis and B. cereus and since previous studies demonstrate it
contains pathogenic activity, some of the recombinant clones used in this study
can be useful for large scale preparation of camelysin for cell culture and
possibly animal models to examine the role it may have in the pathogenicity of
these organisms.
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